首页> 外文会议>Annual NSTI nanotechnology conference and expo >A novel mechanism for the synthesis of ultra-purified silver nanoparticles for the use in biomedical materials
【24h】

A novel mechanism for the synthesis of ultra-purified silver nanoparticles for the use in biomedical materials

机译:合成用于生物医学材料的超纯化银纳米颗粒的新机理

获取原文

摘要

Biomedical products are regulated by high standards of purity and quality compared to those that are not going to be linked to the human body. These requirements are crucial in order to guarantee biocompatibility. For this reason, the price of the final product is going to increase significantly [1]. So it is a real challenge to incorporate a nanotechnological product to be used in the biomedical industry without affecting its cost. Previous research has shown the antibacterial properties of nanoproducts such as silver nanoparticles (AgNPs) and single-walled carbon nanotubes (SWNTs) against infectious agents like bacteria and fungi. However, as mentioned before purity in those products has to reach higher levels than for other applications. Available reagents for the synthesis of AgNPs contain metal impurities such as iron that cannot only reduce the antimicrobial properties but even promote the growth of microbiological agents according to the level of purity of the reagent. In this study, we describe a novel and more affordable mechanism for the synthesis and bio-purification of AgNPs that contain metal impurities. The nanoparticles were synthetized by the use of silver nitrate with different levels of purity. After tests with some species of fungi and bacteria we have found Pseudomonas aeruginosa as the proper specie to the bio-purification and thus obtaining a higher purity of AgNPs . With this novel mechanism, not only we were able to use a reagent with a higher quantity of impurities and reduce the synthesis cost, but also were able to achieve a higher purity in the synthetized nanoparticles. By synthetizing AgNPs this way, we not only obtained nanoparticles with a higher purity than the ones produced by using a higher purity reagent, but also reduced the cost around 50 percent. This method is important because AgNPs synthesized with these properties can be incorporated to polymers for products such as catheters, and alloys such as scalpels with better antimicrobial properties.
机译:与不与人体连接的生物医学产品相比,生物医学产品受到高纯度和高质量标准的监管。这些要求对于保证生物相容性至关重要。因此,最终产品的价格将大幅上涨[1]。因此,将纳米技术产品用于生物医学行业而不影响其成本是一个真正的挑战。先前的研究表明,纳米产品(例如银纳米颗粒(AgNPs)和单壁碳纳米管(SWNTs))对诸如细菌和真菌的传染性细菌具有抗菌作用。但是,如前所述,这些产品的纯度必须达到比其他应用更高的水平。可用的用于合成AgNPs的试剂包含金属杂质,例如铁,这些杂质不仅会降低抗菌性能,而且根据试剂的纯度水平甚至会促进微生物试剂的生长。在这项研究中,我们描述了一种新型且更实惠的机制,用于合成和生物纯化包含金属杂质的AgNP。通过使用具有不同纯度水平的硝酸银来合成纳米颗粒。在对某些种类的真菌和细菌进行测试后,我们发现铜绿假单胞菌是生物纯化的合适种类,因此获得了更高纯度的AgNPs。通过这种新颖的机制,我们不仅能够使用杂质含量更高的试剂并降低合成成本,而且还能在合成的纳米颗粒中获得更高的纯度。通过这种方式合成AgNP,我们不仅获得了比使用高纯度试剂生产的纳米颗粒更高的纯度,而且将成本降低了约50%。该方法之所以重要,是因为可以将具有这些特性的AgNP掺入用于产品(例如导管)和合金(例如解剖刀)的聚合物中,并具有更好的抗菌性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号